Jeil Pharmaceutical Co., Ltd. engages in the development of pharmaceuticals. It operates through the Pharmaceutical and Other business divisions. The Pharmaceutical division offers drugs for antibiotic, oncology, cardiovascular, gastrointestinal, neuropsychiatry, urology, endocrinology, respiratory, antiviral, musculoskeletal, and others. The company was founded on March 7, 1959 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company